Abstract: Bicomponent carbon fibers may comprise an inner region that is at least partially surrounded by an outer sheath, each comprising at least one carbonized pitch. The inner region comprises 70 wt % or greater mesophase pitch that has been carbonized, and the outer sheath comprises up to 70 wt % mesophase pitch that has been carbonized. An amount of mesophase pitch in the outer sheath is lower than in the inner region. The bicomponent carbon fibers may be formed by extrusion of first and second pitch compositions having the requisite amounts of mesophase pitch, followed by carbonization.

Abstract: In some embodiments, an affixed group of pharmaceutical vials with frangible connectors includes: a plurality of pharmaceutical vials arranged as a group of pharmaceutical vials, each of the plurality of pharmaceutical vials shaped and positioned to minimize a total volume of the group of pharmaceutical vials, each of the pharmaceutical vials including at least one external side with a surface configured to reversibly mate with a corresponding external side and a surface of an adjacent pharmaceutical vial; and a plurality of frangible connectors, wherein at least one frangible connector is affixed to the surface of at least two of the plurality of pharmaceutical vials within the group of pharmaceutical vials, and at least one frangible connector is affixed to each of the plurality of pharmaceutical vials.

Abstract: This disclosure relates to cloud migration. In some aspects, a method includes receiving, by one or more computing devices, a plurality of parameters associated with an on-premises system to be migrated to a cloud architecture, the plurality of parameters including an identifier of the on-premises system, identifiers of components of the on-premises system, and migration requirements; extracting, from the plurality of parameters, a set of input parameters substantially affecting a migration of the on-premises system to the cloud architecture; identifying a target cloud architecture, selected from a plurality of cloud architectures, that i) is compliant with the set of input parameters, and ii) satisfies one or more threshold conditions associated with the migration; determining, a set of output parameters representing features of the target cloud architecture; and training, a neural network model using the set of input parameters and the set of output parameters.

Abstract: Multi-monodose containers are described including a row of at least two vials, a first vial connected to an adjacent second vial through an articulating joint, the articulating joint sufficiently flexible to reversibly mate a planar outer surface of the first vial with a planar outer surface of the adjacent second vial; wherein the row of the at least two vials is configured to form a first rectangular packing cross-sectional area in an expanded configuration and configured to form a second rectangular packing cross-sectional area in a folded configuration, the second rectangular packing cross-sectional area smaller than the first rectangular packing cross-sectional area.

Abstract: Methods are described for packaging a foldable container including covering a multi-monodose container in an expanded configuration with a hermetically-sealable overwrap, the multi-monodose container including a row of interconnected monodose pharmaceutical vials, each of the monodose pharmaceutical vials enclosing at least one pharmaceutical agent, the interconnected monodose pharmaceutical vials connected to one another by one or more articulating joints sufficiently flexible to form a folded configuration of the multi-monodose container; exerting a force on at least one of the monodose pharmaceutical vials; bending the one or more articulating joints to form the folded configuration of the multi-monodose container in response to the exerted force; and sealing the hermetically-sealable overwrap to form a hermetic seal around the folded configuration of the multi-monodose container.

Abstract: Methods are described for packaging a foldable container including covering a multi-monodose container in an expanded configuration with a hermetically-sealable overwrap, the multi-monodose container including a row of interconnected monodose pharmaceutical vials, each of the monodose pharmaceutical vials enclosing at least one pharmaceutical agent, the interconnected monodose pharmaceutical vials connected to one another by one or more articulating joints sufficiently flexible to form a folded configuration of the multi-monodose container; exerting a force on at least one of the monodose pharmaceutical vials; bending the one or more articulating joints to form the folded configuration of the multi-monodose container in response to the exerted force; and sealing the hermetically-sealable overwrap to form a hermetic seal around the folded configuration of the multi-monodose container.

Abstract: Methods and devices are described for packaging a multi-monodose container including covering a molded structure with a hermetically-sealable overwrap, the molded structure including a first portion and a second portion, the first portion including a row of interconnected monodose pharmaceutical vials, each of the interconnected monodose pharmaceutical vials enclosing a dose of at least one pharmaceutical agent, the second portion affixed to the first portion and including a textured surface pattern positioned to direct gas flow between the first portion and a region adjacent to the second portion; evacuating at least a portion of air from around the molded structure, the evacuated air at least partially flowing over the textured surface pattern of the second portion; forming a hermetic seal around the row of interconnected monodose pharmaceutical vials; and separating the second portion of the molded structure from the first portion of the molded structure.

Abstract: Multi-monodose containers are described including a row of at least two vials, a first vial connected to an adjacent second vial through an articulating joint, the articulating joint sufficiently flexible to reversibly mate a planar outer surface of the first vial with a planar outer surface of the adjacent second vial; wherein the row of the at least two vials is configured to form a first rectangular packing cross-sectional area in an expanded configuration and configured to form a second rectangular packing cross-sectional area in a folded configuration, the second rectangular packing cross-sectional area smaller than the first rectangular packing cross-sectional area.

Abstract: In some embodiments, an affixed group of pharmaceutical vials with frangible connectors includes: a plurality of pharmaceutical vials arranged as a group of pharmaceutical vials, each of the plurality of pharmaceutical vials shaped and positioned to minimize a total volume of the group of pharmaceutical vials, each of the pharmaceutical vials including at least one external side with a surface configured to reversibly mate with a corresponding external side and a surface of an adjacent pharmaceutical vial; and a plurality of frangible connectors, wherein at least one frangible connector is affixed to the surface of at least two of the plurality of pharmaceutical vials within the group of pharmaceutical vials, and at least one frangible connector is affixed to each of the plurality of pharmaceutical vials.

Abstract: A method and system of a software development using visual action elements is disclosed. In one embodiment, the method includes providing a user interface with action elements, and providing a mechanism for specification and review of the action elements using the user interface. For example, providing a user interface includes providing a prototype of the user interface in a web browser and providing a mechanism for specification and review includes providing a toolbar with functionality to record user comments regarding the action elements. The method may also include providing a user interface to document the user interface. The method may further include providing an animated view of stimulus response behavior of the action elements.

Abstract: User interfaces created for software systems are used as the basis for gathering and/or disseminating requirements, behavioral specifications, review processes, and documentation. A computer readable medium is described, the medium having computer executable instruction to cause a system perform the method.